Pharmerica (PMC) Tops Q1 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
PharMerica Reports First Quarter 2015 Results
May 7, 2015 8:01 AM EDTSolid Year Over Year Improvement in Revenue, Gross Profit, Adjusted EBITDA and Adjusted Diluted Earnings Per Share
Reaffirms Annual 2015 Guidance
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE: PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today reported its financial results for the first quarter ended March 31, 2015.
   1Q15 Results  ÂComparison to
1Q14
  Comparison to4Q14
Revenue $511.6 million Increase of 13.1% Decrease of 2.3% Adjusted EBITDA $37.4 million Increase of 25.9%... More